By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. (ORKA)

NASDAQ Currency in USD
$141.00
+$0.24
+0.17%
Last Update: 18 Jul 2026, 14:26
$6.43bn
Market Cap
-59.00
P/E Ratio (TTM)
Forward Dividend Yield
$104.22-$171.82
52 Week Range

ORKA Stock Price Chart

Explore Oruka Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ORKA price movements and trends.

ORKA Company Profile

Discover essential business fundamentals and corporate details for Oruka Therapeutics, Inc. (ORKA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Aug 1997

Employees

28.00

CEO

Lawrence Otto Klein

Description

Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.

ORKA Financial Timeline

Browse a chronological timeline of Oruka Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 10 Aug 2026

EPS estimate is -$0.49.

Earnings released on 13 May 2026

EPS came in at -$0.48 surpassing the estimated -$0.55 by +12.24%.

Earnings released on 12 Mar 2026

EPS came in at -$0.45 surpassing the estimated -$0.61 by +26.23%.

Earnings released on 12 Nov 2025

EPS came in at -$0.55 surpassing the estimated -$0.56 by +1.79%.

Earnings released on 11 Aug 2025

EPS came in at -$0.46 surpassing the estimated -$0.48 by +4.17%.

Earnings released on 14 May 2025

EPS came in at -$0.40 surpassing the estimated -$0.57 by +29.82%.

Earnings released on 6 Mar 2025

EPS came in at -$0.49 surpassing the estimated -$0.68 by +27.94%.

Earnings released on 13 Nov 2024

EPS came in at -$1.46 falling short of the estimated -$0.40 by -265.00%.

Stock split effective on 3 Sept 2024

Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.

Dividend declared on 29 Aug 2024

A dividend of $1.61 per share was announced, adjusted to $19.36.

Earnings released on 27 Aug 2024

EPS came in at -$1.53 .

Earnings released on 25 Apr 2024

EPS came in at -$0.14 .

Earnings released on 31 Dec 2023

EPS came in at -$0.08 .

Earnings released on 30 Sept 2023

EPS came in at -$0.10 .

Earnings released on 30 Jun 2023

EPS came in at -$0.10 .

Earnings released on 31 Mar 2023

EPS came in at -$0.09 .

Earnings released on 31 Dec 2022

EPS came in at -$0.98 .

Earnings released on 30 Sept 2022

EPS came in at -$1.94 .

Earnings released on 30 Jun 2022

EPS came in at -$2.62 .

Earnings released on 31 Mar 2022

EPS came in at -$2.72 .

Earnings released on 31 Dec 2021

EPS came in at -$4.73 surpassing the estimated -$26.88 by +82.42%.

Earnings released on 30 Sept 2021

EPS came in at -$3.92 surpassing the estimated -$27.60 by +85.78%.

ORKA Stock Performance

Access detailed ORKA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run